FDA
approval
· 2018-06-11
FDA Approved: SUBOXONE — Supplemental Application (INDIVIOR INC.)
Summary
FDA approved a supplemental application for SUBOXONE (buprenorphine/naloxone) submitted by INDIVIOR INC., approving changes to the existing approval under NDA 0…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SUBOXONE (BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE)